Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The burden of Progressive Fibrotic Interstitial lung disease across the UK

Thomas Simpson, Shaney L Barratt, Paul Beirne, Nazia Chaudhuri, Anjali Crawshaw, Louise E Crowley, Sophie Fletcher, Michael A Gibbons, Philippa Hallchurch, Laura Horgan, Ieva Jakaityte, Thomas Lewis, Tom McLellan, Ryan Miller, Stefan Stanel, Muhunthan Thillai, Fiona Thompson, Zhe Wu, View ORCID ProfilePhilip L Molyneaux, Alex G West
doi: https://doi.org/10.1101/2020.11.16.20229591
Thomas Simpson
1Department of Respiratory Medicine, Guy’s and St Thomas’ NHS Foundation Trust, Great Maze Pond, London SE1 9RT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaney L Barratt
2Bristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol UK
3Academic Respiratory Unit, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Beirne
4Leeds interstitial Lung Disease Service, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazia Chaudhuri
5North West Lung Centre, Wythenshawe Hospital, Manchester M23 9LT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anjali Crawshaw
6Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise E Crowley
6Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Fletcher
7University Hospitals Southampton NHS Foundation Trust, Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A Gibbons
8South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Barrack Road, Exeter EX2 5DW, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippa Hallchurch
2Bristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Horgan
4Leeds interstitial Lung Disease Service, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ieva Jakaityte
8South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Barrack Road, Exeter EX2 5DW, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Lewis
2Bristol Interstitial Lung Disease Service, North Bristol NHS trust, Southmead Hospital, Bristol UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom McLellan
9Department of Interstitial Lung Disease, Royal Papworth Hospital NHS Foundation Trust, Cambridge UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Miller
8South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Barrack Road, Exeter EX2 5DW, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Stanel
5North West Lung Centre, Wythenshawe Hospital, Manchester M23 9LT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhunthan Thillai
9Department of Interstitial Lung Disease, Royal Papworth Hospital NHS Foundation Trust, Cambridge UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Thompson
7University Hospitals Southampton NHS Foundation Trust, Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhe Wu
10National Heart and Lung Institute, Imperial College London, UK
11Royal Brompton Hospital, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip L Molyneaux
10National Heart and Lung Institute, Imperial College London, UK
11Royal Brompton Hospital, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philip L Molyneaux
  • For correspondence: p.molyneaux@imperial.ac.uk
Alex G West
1Department of Respiratory Medicine, Guy’s and St Thomas’ NHS Foundation Trust, Great Maze Pond, London SE1 9RT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

While Idiopathic pulmonary fibrosis (IPF) remains the exemplar progressive fibrotic lung disease, there remains a cohort of non-IPF fibrotic lung diseases (fILD) which adopt a similar clinical behaviour to IPF despite therap. This phenotypically related group of conditions, where progression of disease is similar to that seen in IPF, have recently been described as Progressive Fibrotic Interstitial Lung diseases (PF-ILD). Previous estimates suggest that between 18 to 40% of all fILD will develop progressive disease, however, the exact burden remains unknown. This retrospective, observational study therefore aimed to estimate the incidence of PF-ILD across England.

All new referrals seen across nine UK centres for their first outpatient clinic appointment between 1st August 2017 and 31st January 2018 were assessed against the diagnostic criteria for PF-ILD laid out in the INBUILD trial. A total of 1749 patients with fILD were assessed. In this cohort of patients at risk of developing PF-ILD the INBUILD criteria were met in 14.5% (253/1749) of all new non-IPF fILD referrals. The average time from referral to specialist centre to diagnosis of progressive phenotype was 311 days. Of the progression events the majority were driven by a measured drop in FVC, with more than half of patients experiencing a drop of 10%. Almost one quarter of patients (24.1%) were diagnosed with progressive disease on the basis of radiological and symptomatic progression alone without a spirometric deterioration.

This study represents a fair and balanced approach to assessing the incidence of objectively measurable and treatable PF-ILDs in the UK. A rate of 14.5% of new referrals with non-IPF ILD is less than that reported in previous studies however our methodology is likely to give a more accurate result than estimates based on extrapolation from general disease statistics, from physician-reported estimates prone to significant biases, or insurance claim processes also substantially prone to bias. This information has implication for workforce planning and the funding of anti-fibrotic therapy in the UK and beyond.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

PLM is supported by an Action for Pulmonary Fibrosis Mike Bray fellowship.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This project was internally submitted as a service improvement and accepted by the quality improvement and patient safety committee prior to commencement, and external ethical approval was not required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: PLM is supported by an Action for Pulmonary Fibrosis Mike Bray fellowship.

Data Availability

Anonymised data is available on request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The burden of Progressive Fibrotic Interstitial lung disease across the UK
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The burden of Progressive Fibrotic Interstitial lung disease across the UK
Thomas Simpson, Shaney L Barratt, Paul Beirne, Nazia Chaudhuri, Anjali Crawshaw, Louise E Crowley, Sophie Fletcher, Michael A Gibbons, Philippa Hallchurch, Laura Horgan, Ieva Jakaityte, Thomas Lewis, Tom McLellan, Ryan Miller, Stefan Stanel, Muhunthan Thillai, Fiona Thompson, Zhe Wu, Philip L Molyneaux, Alex G West
medRxiv 2020.11.16.20229591; doi: https://doi.org/10.1101/2020.11.16.20229591
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The burden of Progressive Fibrotic Interstitial lung disease across the UK
Thomas Simpson, Shaney L Barratt, Paul Beirne, Nazia Chaudhuri, Anjali Crawshaw, Louise E Crowley, Sophie Fletcher, Michael A Gibbons, Philippa Hallchurch, Laura Horgan, Ieva Jakaityte, Thomas Lewis, Tom McLellan, Ryan Miller, Stefan Stanel, Muhunthan Thillai, Fiona Thompson, Zhe Wu, Philip L Molyneaux, Alex G West
medRxiv 2020.11.16.20229591; doi: https://doi.org/10.1101/2020.11.16.20229591

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (173)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)